Apax Partners' Unilabs to buy Biopath, Polibio, SFMTBio
Apax Partners-backed Unilabs, a Swiss diagnostics labs group, is to acquire France-based medical biology laboratory operators Biopath, Polibio and SFMTBio, according to an announcement from the French competition authority.
More on Expansion
Toscafund leads €25m round for Elinvar
Existing investors Goldman Sachs Growth, Ampega and Finleap also back the round
BGF invests £4m in CSN
For the year ending on 31 March 2020, the company generated £1.6m in EBITDA, from revenues of £27.1m
Lightspeed leads $20m Wintermute series-B
Lightspeed led the company's series-A funding round in June 2020, following another round in January
Aurica Capital invests in SamyRoad
Aurica intends to support the company in further expanding its customer base and boosting its international development
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018